Full CoverageBreakthrough Alzheimer's drugs too pricey to be offered on NHS
By James Gallagher
All coverage
Lilly to appeal after UK agency opposes reimbursement for Alzheimer's drug
By Sriparna Roy & Devika Syamnath
Thousands of NHS patients denied breakthrough Alzheimer’s drugs
By Holly Bancroft
Breakthrough dementia drugs rejected AGAIN for use on NHS – as experts blast it ‘can’t keep up with scien...
By Sam Blanchard
Not Over Yet: Eisai And Lilly To Appeal England’s ‘Flawed’ Refusal To Fund Leqembi And Kisunla
By Neena Brizmohun
NHS patients battling Alzheimer's WON'T be offered 'miracle' drugs as health watchdog rules they are 'too expensive to justify'
By Emily Cooper
NHS patients denied first drugs that treat Alzheimer’s
By Eleanor Hayward